May 2024 Newsletter, Marquee
Centre for Cellular and Molecular Platforms (C-CAMP)
Fostering deep science research and innovation for societal impact
April has been eventful at C-CAMP. With 2 MoU pact signings, a technology showcase, soon to commence clinical trials for a rare disease and the first-in-series of WHO workshops for India's booming diagnostics sector!
A glimpse through what's in store in this edition of Marquee ??
Scroll below to take your pick!
C-CAMP joins hands with All India Council For Technical Education (AICTE) to Foster Bio-Medical Innovations at University Level
C-CAMP with AICTE has launched the AICTE C-CAMP Inter Institutional Biomedical Innovation Programme Initiative (Swayam Nirbhar) to foster India's engineering and medical community's phenomenal talent in a structured framework to ignite problem identification, ideation and development of life-saving biomedical products in close cross disciplinary collaborations. Know More
C-CAMP joins Blockchain For Impact-Biome's Virtual Network Program to Transform Healthcare in India
C-CAMP has a robust pipeline of biomedical innovations in several critical areas such as infectious disease diagnostics, antimicrobial resistance, cell therapy, immuno-oncology, regenerative tissues, digital health tech to name a few. This partnership with Blockchain for Impact (BFI) - Biome will strengthen India’s healthcare system and improve public access to quality healthcare in all these critical areas. Know More
Third Technology Showcase for the Biotech Industry
A platform that connects deep-science inventors and innovators with industry partners to advance the productization of cutting-edge technologies, the 3rd Tech Showcase organized by C-CAMP's Office of Tech Transfer was a success! It showcased products targeting healthcare sectors such as bone diseases, genetic disorders such as sickle cell disease, diagnostics, respiratory disorders for neonates and adults, therapeutics to curb AMR, wound healing and what not! Know More
Dream BIG with C-CAMP
Chase your BIG dreams by partnering with C-CAMP for Biotechnology Ignition Grant Call 24. Since the inception of the grant in 2012, CCAMP has been a BIG partner! Till date we have supported 200+ BIG innovations who have gone onto raise multiple follow-on-fundings & have reached commercialization stage Know more
Missed on our proposal writing workshop on how to ? Check here
C-CAMP proudly welcomes its new bunch of startups and innovators under Biotechnology Ignition Grant
As their partner in journey towards BIG future, C-CAMP welcomes these 10 exciting innovators & celebrates their ideas in Drugs & related areas, Diagnostics, Medical devices, Agriculture & allied areas. Know more
领英推荐
Laying Foundations for India to become the Diagnostics capital of the World
In collaboration with World Health Organization India and supported by the Gates Foundation India , C-CAMP Indigenisation of Diagnostics program organized a workshop for 30 cohort companies on "Global landscape for development & manufacturing of in vitro diagnostics (IVDs) with regulatory requirements in India." Know More
C-CAMP Startups take the Centre-Stage Globally
Eyestem Research to begin 1st human trials for Geographic Atrophy
C-CAMP supported startup Eyestem Research has received the approval from CDSCO to start 1st in human trials for their stem cell based therapy, Eyecyte-RPE for treatment of Geographic Atrophy, secondary to Dry AMD. This will be the first time, an affordable stem cell based therapy for such a disease will be available for clinical purposes in India, post completion of a successful clinical trial. Know More
2 Startups clear major global regulatory marks!
C-CAMP startup Biomoneta 's Avata Rx Medical Grade Air sterilizer has completed the initial phase of Medical Device (MD) compliance testing in India. It is on the way to become nation's first US FDA-approved air sterilizer. Know More
Also, PathFlowDx, a digital pathology workflow software developed by C-CAMP supported Onward Assist has received CE certification and is now available in the European market! Know More
Nesa Medtech Receives Global Recognition
Supported startup Nesa Medtech has been selected as one of the top seven startups for the OB/GYN Innovation Award by Femtech World World. Their flagship product, GYIDE, is a novel minimally invasive, safe, effective and uterus-preserving technology to treat uterine fibroids. Know More
Centre for Cellular and Molecular Platforms
C-CAMP, GKVK Post, Bellary Road, 560065, Bengaluru | Website: www.ccamp.res.in | Subscribe to all our newsletters - https://www.ccamp.res.in/subscribe | Get in touch: [email protected]